Literature DB >> 10443293

Expression of multiple matrix metalloproteinases and urokinase type plasminogen activator in cultured Kaposi sarcoma cells.

L C Meade-Tollin1, D Way, M H Witte.   

Abstract

Kaposi's sarcoma (KS) cells are considered to be of endothelial origin. KS lesions are characterized by hyperproliferation and an invasive phenotype. We have determined that KS cell cultures constitutively secrete multiple forms of several matrix metalloproteinases (MMPs) and an altered form of urokinase plasminogen activator (uPA) by zymogram and Western analysis of the culture media. MMPs are a family of secreted endoproteinases which degrade components of the extracellular matrix. Their enhanced expression and activity are strongly correlated with cellular processes involving tissue remodeling and invasion. The KS cells secrete increased levels of gelatinase A and B and a high molecular weight uPA in vitro when compared with non-KS endothelial or epithelial cells. Multiple forms of gelatinases A and B were observed on gelatin zymograms. Caseinolytic bands observed were confirmed by Western blot analysis to be due to stromelysin activity, whereas matrilysin was not detected by casein zymography. Western blot analysis also detected secretion of interstitial collagenase and high molecular weight uPA. Gelatinolytic activity with the mobility of gelatinase B was detected on gelatin zymograms, but not by Western analysis. This unusual constitutive expression pattern of MMPs and uPA by KS cells in vitro is characterized by elevated levels of gelatinase A, gelatinase B, interstitial collagenase, stromelysin and a high molecular weight form of uPA, and the lack of expression of matrilysin. These secreted MMPs, taken together, are capable of digesting a broad range of components of the extracellular matrix. This unusual pattern is likely to contribute to the characteristic hyperproliferative and invasive phenotype of KS lesions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10443293     DOI: 10.1016/S0065-1281(99)80031-2

Source DB:  PubMed          Journal:  Acta Histochem        ISSN: 0065-1281            Impact factor:   2.479


  9 in total

1.  Osteoactivin regulates head and neck squamous cell carcinoma invasion by modulating matrix metalloproteases.

Authors:  Oneida A Arosarena; Eric W Barr; Ryan Thorpe; Hilary Yankey; Joseph T Tarr; Fayez F Safadi
Journal:  J Cell Physiol       Date:  2017-04-25       Impact factor: 6.384

2.  KSHV Down-regulates Tropoelastin in Both an in-vitro and in-vivo Kaposi's Sarcoma Model.

Authors:  Donald J Alcendor
Journal:  J Oncobiomarkers       Date:  2015

3.  Endothelin receptor blockade inhibits molecular effectors of Kaposi's sarcoma cell invasion and tumor growth in vivo.

Authors:  Laura Rosanò; Francesca Spinella; Valeriana Di Castro; Maria Rita Nicotra; Adriana Albini; Pier Giorgio Natali; Anna Bagnato
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

Review 4.  AIDS-associated Kaposi's sarcoma: is there still a role for interferon alfa?

Authors:  Susan E Krown
Journal:  Cytokine Growth Factor Rev       Date:  2007-07-25       Impact factor: 7.638

5.  Kaposi's sarcoma-associated herpesvirus infection promotes invasion of primary human umbilical vein endothelial cells by inducing matrix metalloproteinases.

Authors:  Li-Wu Qian; Jianping Xie; Fengchun Ye; Shou-Jiang Gao
Journal:  J Virol       Date:  2007-04-18       Impact factor: 5.103

6.  Kaposi Sarcoma Pathogenesis: A Triad of Viral Infection, Oncogenesis and Chronic Inflammation.

Authors:  Janet L Douglas; Jean K Gustin; Ashlee V Moses; Bruce J Dezube; Liron Pantanowitz
Journal:  Transl Biomed       Date:  2010

7.  Early increases in plasminogen activator activity following partial hepatectomy in humans.

Authors:  David Mangnall; Kirsty Smith; Nigel C Bird; Ali W Majeed
Journal:  Comp Hepatol       Date:  2004-12-23

8.  The inflammatory kinase MAP4K4 promotes reactivation of Kaposi's sarcoma herpesvirus and enhances the invasiveness of infected endothelial cells.

Authors:  Darya A Haas; Kiran Bala; Guntram Büsche; Magdalena Weidner-Glunde; Susann Santag; Semra Kati; Silvia Gramolelli; Modester Damas; Oliver Dittrich-Breiholz; Michael Kracht; Jessica Rückert; Zoltan Varga; György Keri; Thomas F Schulz
Journal:  PLoS Pathog       Date:  2013-11-07       Impact factor: 6.823

Review 9.  KSHV-Mediated Angiogenesis in Tumor Progression.

Authors:  Pravinkumar Purushothaman; Timsy Uppal; Roni Sarkar; Subhash C Verma
Journal:  Viruses       Date:  2016-07-20       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.